                         SEQUENCE LISTING

<110>  The General Hospital Corporation
       BioVentures, LLC
       Li, Hong-yu
       Yan, Wei
       Lan, Li
 
<120>  COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF 
       CANCER

<130>  125141.03639

<150>  63/062,618
<151>  2020-08-07

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  35
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRIM28 siRNA

<400>  1
gcggaaaugu gagcguguac acgcucacau uuccg                                  35


<210>  2
<211>  29
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1-F-EcoRI

<400>  2
ccggaattct gatggagccc ctgcgggtg                                         29


<210>  3
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1-R-BamH1

<400>  3
cgcggatcct tattcatata agattttgat tag                                    33


<210>  4
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1 K122R-F

<400>  4
cttttggaaa atgttagagg ttttgaagta tct                                    33


<210>  5
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1 K122R-R

<400>  5
agatacttca aaacctctaa cattttccaa aag                                    33


<210>  6
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1 K251R-F

<400>  6
agtgatctct ctgtgagaat gctaaaagat ttt                                    33


<210>  7
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1 K251R-R

<400>  7
aaaatctttt agcattctca cagagagatc act                                    33


<210>  8
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1 G155V-F

<400>  8
ttatctccaa cctctcttgt cattccaaat tcaaggctac                             40


<210>  9
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- TRDMT1 G155V-R

<400>  9
gtagccttga atttggaatg acaagagagg ttggagataa                             40


<210>  10
<211>  25
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- SYCP2 siRNA

<400>  10
guccaaggaa ucaugaugaa cuuaa                                             25


<210>  11
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic- KR

<400>  11

Lys Arg Tyr Lys Thr Lys Asp Asp Ile Lys Ser Thr Arg Lys Leu Lys 
1               5                   10                  15      


Glu 
    


<210>  12
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic- M1810-8112KRAA

<400>  12

Ala Ala Tyr Lys Thr Lys Asp Asp Ile Lys Ser Thr Arg Lys Leu Lys 
1               5                   10                  15      


Glu 
    


<210>  13
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic- M1822-8272KRAA

<400>  13

Lys Arg Tyr Lys Thr Lys Asp Asp Ile Lys Ser Thr Ala Ala Ala Ala 
1               5                   10                  15      


Ala 
    


<210>  14
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic- M1810-8272KRAA

<400>  14

Ala Ala Tyr Ala Ala Ala Ala Asp Ile Lys Ser Thr Ala Ala Ala Ala 
1               5                   10                  15      


Ala 
    


<210>  15
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic- LV-TRDMT1-RNAi

<400>  15
gcagaagaaa ttcacaggaa a                                                 21


